Sylvester Comprehensive Cancer Center

E-mail a Friend

Raja Mudad, M.D.

General Information

Raja  Mudad, M.D.

Contact

  • Fax: 954-874-9175

Languages

  • English
  • Spanish
  • French
  • Arabic

Certifications

  • American Board of Internal Med-Hematology
  • American Board of Internal Med-Medical Oncology

CV

Specialties

  • Hematology/Oncology - Internal Medicine
  • Internal Medicine

Roles

  • Assistant Professor of Clinical Medicine

Clinical Interests

Thoracic Cancer
Head & Neck Cancer

Awards

Patients' Choice Award
Physician of the year award, Memorial Cancer Institute
Leadership Recognition Award, Inpatient Oncology Unit, Memorial Regional Hospital, Hollywood, FL,
Compassionate Doctor Recognition
On-Time Doctor Award
Patient's' Choice Award

Education

1992-1995 Fellowship
Duke University Medical Center
1990-1992 Internal Medicine
Duke University Medical Center
1989-1990 Internship
Duke University Medical Center
1985-1989 Doctor of Medicine
American University of Beirut
1982-1985 Bachelor of Science
American University of Beirut

Publications

  • Mudad R, Zakris E, Kovitz K, Nedzi L. Non-malignant pericardial effusion as a long-term complication of combined modality therapy in non-small cell lung cancer (NSCLC). Lung Cancer Vol. 49, Suppl. 2 (2005), pS173, Abstract P220. 11th World Conference on Lung Cancer, Barcelona, Spain July 2005 (Poster presentation, outstanding poster)
  • Higgins K, Gilbert J, Mudad R, Friedlander B, Fazekas M, Pou A, Wisdom G, Hanner S, Zakris E, Nedzi L: Variables associated with missed days of radiation in patients undergoing curative therapy for squamous cell carcinoma of the Head and Neck Poster presentation at ASTRO 2005, Denver, Colorado.
  • K. Higgins, J. Gilbert, R. Mudad, P. Friedlander, M. Fazekus, A. Pou, G. Wisdom, S. Hanner, E. Zakris and L. Nedzi: Socioeconomic Study of Mortality in Patients Undergoing Curative Radiation Therapy (RT) for Squamous Cell Carcinoma (SCC) of the Head and Neck. Poster presentation at ESTRO 2005, Paris, France.
  • Nedzi L, Walsh J. W, Weiner R, Payne B. R, Zakris E, Sanford R, Pearman T, Rosel P, Mudad R, Hall A, Weber J: Localized Therapy for Limited Metastatic Disease to the Brain: A Phase II Study of Surgery, Stereotactic Radiosurgery(SRS) and Stereotactic Radiotherapy(SRT) in Favorable Patients. Poster Presentation at ISRS 2005, Brussels, Belgium.
  • Mudad R, Block M, Forsyth P, Frankel C, Annesty D, Hussein A: Feasibility of lung cancer screening in a South Florida community. Poster Presentation at the 1st European Lung cancer conference, Geneva, Switzerland, April 2008 (abstract # 99) (Oral presentation)
  • Nedzi L, Walsh J, Weiner R, Zakris E, Sanford R, Pearman T, Mudad R, Timmerman, R, Mickey, B, Abdulrahman,R, Madden, C, Whitworth, A and Crockett, J: Localized Therapy for Limited Metastatic Disease to the Brain: A Phase II Study of Surgery, Stereotactic Radiosurgery and Stereotactic Radiotherapy in Favorable Patients: Final results. Poster Presentation at ISRS 2011
  • L.E. Raez, C. Sareli, Raja Mudad, F. Tarrazzi, Evelio Velis, S. Sundararaman, M. Block: Exploring Disparities in Health Care Outcomes in minority populations with Small (SCLC) and Non-small cell lung cancers (NSCLC). Abstract presentation at the World Lung Cancer Conference, Sydney, Australia, October 2013.
  • Raja Mudad, Manish B Patel, Sandra Margunato-Debay, Lincy S. Lal, David Garofalo (University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Celgene Corporation, Summit, NJ, Cardinal Health): Comparative effectiveness and safety of nab-paclitaxel plus carboplatin (nab-P/C) versus gemcitabine plus carboplatin (gem/C) in first-line treatment of advanced squamous cell (SCC) non-small cell lung cancer (NSCLC) in a U.S. community oncology setting. NCCN Annual Conference 20

Biography

Dr. Mudad received his B.S. in Biology with high distinction in 1985 and his M.D. with distinc-tion in 1989 from the American University of Beirut. He completed an internship and residency in 1992 in Internal Medicine and a fellowship in Hematology and Medical Oncology in 1995 at Duke University Medical Center in Durham, North Carolina. In 1995 Dr. Mudad  joined the Tulane University faculty as Associate in Medicine in the Section of Hematology and Medical Oncology. He was promoted to Assistant Professor of Medicine in 1996 and in July of 2001 to the rank of Associate Professor of Medicine. In 1996 Dr. Mudad was appointed Chief of the Section of Hematology/Oncology at the Veterans Administration Medical Center in New Orleans and was also the Associate Chief, Section of Hematology and Medical Oncology at Tulane Medical School and Director of Hematology/Oncology Fellowship Training between 2001-2006. Dr Mudad's primary interest and research is in the field of solid tumor oncology and specifically lung cancer. He has conducted several clinical trials in lung, prostate, head & neck and bladder cancers.

E-mail a Friend